These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 703530)

  • 21. Effects of 6-hydroxydopamine on the hypothalamo-pituitary-adrenocortical axis.
    Nicholson S; Holmes M; Sutanto W; Watts S; Campbell E; Gillham B; Jones M
    Neuroendocrinology; 1986; 43(4):483-90. PubMed ID: 3018609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of 6-hydroxydopamine on the behavior of rats with differing resistance to stress exposure].
    Gromova EA; Semenova TP; Gasanov GG; Ismaĭlova KhIu; Fast AE; Nesterova IV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(2):301-9. PubMed ID: 2166392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 6-hydroxydopamine on hypothalamic norepinephrine and dopamine content, ultrastructure of the median eminence, and plasma corticosterone.
    Cuello AC; Shoemaker WJ; Ganong WF
    Brain Res; 1974 Sep; 78(1):57-69. PubMed ID: 4376442
    [No Abstract]   [Full Text] [Related]  

  • 24. Intra- and extraneuronal formation of the two major noradrenaline metabolites in the cns of rats.
    Braestrup C; Nielsen M
    J Pharm Pharmacol; 1975 Jun; 27(6):413-9. PubMed ID: 237089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 6-Hydroxydopamine: effect on mouse brain monoamines and 14C-noradrenaline uptake.
    Masuoka DT; Alcaraz AF
    Eur J Pharmacol; 1973 Nov; 24(2):234-42. PubMed ID: 4765746
    [No Abstract]   [Full Text] [Related]  

  • 27. [Role of brain biogenic amines in the central thermoregulatory mechanism of the rat (author's transl)].
    Fukushima N
    Hokkaido Igaku Zasshi; 1975 Jul; 50(4):369-85. PubMed ID: 1240080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of noradrenaline denervation-induced increase of beta-adrenoreceptor binding in rat neocortex by noradrenaline infusion.
    Biswas B; Jonsson G
    Eur J Pharmacol; 1981 Jan; 69(3):341-6. PubMed ID: 6260513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of intraventricular injections of 6-hydroxydopamine in neonatal rats on the catecholamine levels and tyrosine hydroxylase activity in brain regions at maturity.
    Peters DA; Pappas BA; Taub H; Saari M
    Biochem Pharmacol; 1977 Dec; 26(23):2211-5. PubMed ID: 22332
    [No Abstract]   [Full Text] [Related]  

  • 31. Failure of 6-hydroxydopamine to abolish the circadian rhythm of serum corticosterone.
    Ulrich RS; Yuwiler A
    Endocrinology; 1973 Feb; 92(2):611-4. PubMed ID: 4682873
    [No Abstract]   [Full Text] [Related]  

  • 32. Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence.
    von Euler G; Meister B; Hökfelt T; Eneroth P; Fuxe K
    Brain Res; 1990 Oct; 531(1-2):253-62. PubMed ID: 1981163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. II. On the central monoaminergic innervation.
    Bourgoin S; Adrien J; Laguzzi RF; Dolphin A; Bockaert J; Hery F; Hamon M
    Brain Res; 1979 Jan; 160(3):461-78. PubMed ID: 421125
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of 6-hydroxydopamine and some hypotensive drugs on lypressin induced hypertension in rats.
    Szadowska A; Szmigielska H; Szmigielski A; Kamińska A; Wejman I
    Pol J Pharmacol Pharm; 1985; 37(4):487-93. PubMed ID: 3936030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of the 6-hydroxydopamine-induced suppression of a CAR by drugs facilitating central catecholaminergic mechanisms.
    Ruiz M; Monti JM
    Pharmacology; 1975; 13(4):281-6. PubMed ID: 1187753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of intraventricular 6-hydroxydopamine and replacement therapy with norepinephrine, dopamine, and serotonin on self-stimulation in diencephalic and mesencephalic regions in the rat.
    Olds ME
    Brain Res; 1975 Nov; 98(2):327-42. PubMed ID: 1182523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of central early postnatal 6-hydroxydopamine administration on brain catecholamines and pituitary-adrenal function in adulthood.
    Kaplanski J; Nyakas C; van Delft AM; Smelik PG
    Neuroendocrinology; 1973-1974; 13(1):123-7. PubMed ID: 4779045
    [No Abstract]   [Full Text] [Related]  

  • 38. Central catecholamine and peripheral noradrenaline depletion by 6-hydroxydopamine and active avoidance learning in rats.
    Oei TP; King MG
    J Comp Physiol Psychol; 1978 Feb; 92(1):94-108. PubMed ID: 627641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diuretic action of noradrenaline and dopamine in rats with chemical serotoninectomy and central nervous system sympathectomy.
    Brus R; Szkilnik R; Stanosek B; Herman ZS
    Acta Physiol Pol; 1983; 34(3):339-43. PubMed ID: 6687102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shock-induced aggression: opposite effects of intraventricularly infused dopamine and norepinephrine.
    Geyer MA; Segal DS
    Behav Biol; 1974 Jan; 10(1):99-104. PubMed ID: 4856062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.